Evaluating of Anti-Diabetic Potential and Beneficial Effect of Nutraceutical Powder in Management of Various Diabetic Complication
Main Article Content
Abstract
Diabetes mellitus is a chronic disorder that generates raised more blood glucose levels due to insufficient insulin production or activity. This illness's metabolic imbalance raises the likelihood of long-term problems in blood vessels, resulting in frequent hospitalization and increased risk of cardiovascular disease. Providing appropriate treatment to diabetic patients is vital to avert complications. Female Wistar rats were divided into different groups (n = 6). Eight groups each one induced alloxan to type1 diabetes and treated with different doses of nutraceutical powder. 24 h after the last dose, animals were subjected to behavioural, biochemical, and histopathological evaluations. The data were analysed by one-way ANOVA. In in-vitro model of alpha amylase inhibition assay the absorbance of sample increased as the concentration of nutraceutical powder will increase. In alloxan induced in vivo diabetic model in Wistar rats the body weight, the water intake observed the increasing in disease control as comparing to normal, standard, Test drug group1 lower dose(200mg/kg) and Test drug group 2(500mg/kg), the food intake observed the decreasing in disease control as comparing to normal, standard, Test drug group1 lower dose(200mg/kg) and Test drug group 2(500mg/kg).After 45 days of study, all biochemical parameters the blood, LDL, insulin and creatinine level observed the increasing in disease control group with comparing to normal control, standard control and tests groups. The study will conclude our formulation has potential for managing diabetes by stimulating the regeneration of pancreatic β-cells and further research is needed to understand the active constituents and mechanism of action.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Anoop, S., & Firdous, S. (2016). Effect of Ipomoea staphylina leaves on streptozotocin-nicotinamide induced type-II diabetes in Wistar rats. Asia Pacific Journal of Health Sciences, 3(3), 30–44.
Castell, J. V., Friedrich, G., Kuhn, C. S., & Poppe, G. E. (1997). Intestinal absorption of undegraded proteins in men: Presence of bromelain in plasma after oral intake. American Journal of Physiology, 273(1), G139–G146. https://doi.org/10.1152/ajpgi.1997.273.1.G139
Dafriani, P., Karamika, M., Anggraini, S. S., & Marlinda, R. (2020). The Potential of Noni (Moringa citrifolia) in Lowering Blood Glucose Levels in Diabetes Mellitus Patients. group, 199(88), 37-441. https://doi.org/10.22236/j.bes/424919
de Bem, G. F., Costa, C. A., Santos, I. B., Cristino Cordeiro, V. D. S., de Carvalho, L. C. R. M., de Souza, M. A. V., Soares, R. A., Sousa, P. J. D. C., Ognibene, D. T., Resende, A. C., & de Moura, R. S. (2018). Antidiabetic effect of Euterpe oleracea Mart. (açaí) extract and exercise training on high-fat diet and streptozotocin-induced diabetic rats: A positive interaction. PLoS One, 13(6), e0199207. https://doi.org/10.1371/journal.pone.0199207
Ishnava, K. B., & Motisariya, D. M. (2018). In-vitro study on α-amylase inhibitory activity of selected ethnobotanical plant extracts and its herbal formulations. International Journal of Pharmacognosy and Chinese Medicine, 2(3). https://doi.org/10.23880/IPCM-16000136
Jarald, E., Joshi, S. B., & Jain, D. (2008). Diabetes and herbal medicines. Pharmacognosy Review, 2(4), 97–106.
Katiyar, D. (2019). Amelioration of diabetes and its related complications in streptozotocin-induced diabetic rats by herbal formulations. International Journal of Pharmaceutical and Phytopharmacological Research, 9(2), 1–13., 10(2), 130-134.
Lakhtakia, R. (2013). The history of diabetes mellitus. Sultan Qaboos University Medical Journal, 13(3), 368–370. https://doi.org/10.12816/0003257
Lin, J., Thompson, T. J., Cheng, Y. J., Zhuo, X., Zhang, P., Gregg, E., & Rolka, D. B. (2018). Projection of the future diabetes burden in the United States through 2060. Population health metrics, 16, 1-9. https://doi.org/10.1186/s12963-018-0166-4
National Institute for Health and Care Excellence (NICE). (2015). Type 2 diabetes in adults: management. London: NICE.
Roglic, G. (2016). WHO global report on diabetes: A summary. International Journal of Noncommunicable Diseases, 1(1), 3–.
Sayeli, V. K., & Shenoy, A. K. (2021). Antidiabetic effect of bio-enhanced preparation of turmeric in streptozotocin-nicotinamide induced type 2 diabetic Wistar rats. Journal of Ayurveda and Integrative Medicine, 12(3), 474–479. https://doi.org/10.1016/j.jaim.2021.04.010
Sheikh, J. R., & Patil, M. (2020). Qualitative tests for preliminary phytochemical screening: An overview. International Journal of Chemical Studies, 8(2), 603–608.
Son, Y., Lee, H., Son, S.-Y., Lee, C.-H., Kim, S.-Y., & Lim, Y. (2021). Ameliorative effect of Annona muricata (Graviola) extract on hyperglycemia-induced hepatic damage in type 2 diabetic mice. Antioxidants, 10(10), 1546. https://doi.org/10.3390/antiox10101546
World Health Organization. (2024). Definition diabetes. Health topics: Diabetes. Retrieved from https://www.who.int/health-topics/diabetes